Participating Faculty: Redefining Hemophilia Management: Treatment Goals, Nonfactor Replacement Therapies, and the Role of Fitusiran

Faculty

Steven W. Pipe, MD

Professor of Pediatrics and Pathology

University of Michigan

Ann Arbor, MI

Faculty Disclosures

The following have relevant commercial financial relationships or affiliations to disclose:

Steven W. Pipe, MD, reports the following relevant commercial financial relationships or affiliations in the past 12 months:

CONSULTANCIES OR PAID ADVISORY BOARDS

Bayer, BioMarin, Chugai, CSL Behring, HEMA Biologics, Inovio, LFB, Metagenomi, Novo Nordisk, Pfizer, Roche/Genentech/Spark Therapeutics, Sanofi, Star Therapeutics, and Takeda

LECTURE FEES AT THE INVITATION OF A COMMERCIAL SPONSOR

Chugai, Roche, Sanofi

MEETING/CONFERENCE ATTENDANCE

Sanofi

SCIENTIFIC ADVISORY BOARDS

Equilibra, GeneVentiv